Navigation Links
How eating fruit and vegetables can improve cancer patients' response to chemotherapy
Date:10/22/2008

RIVERSIDE, Calif. The leading cause of death in all cancer patients continues to be the resistance of tumor cells to chemotherapy, a form of treatment in which chemicals are used to kill cells.

Now a study by UC Riverside biochemists that focuses on cancer cells reports that ingesting apigenin a naturally occurring dietary agent found in vegetables and fruit improves cancer cells' response to chemotherapy.

Xuan Liu, a professor of biochemistry, and Xin Cai, a postdoctoral researcher working in her lab, found that apigenin localizes tumor suppressor p53, a protein, in the cell nucleus a necessary step for killing the cell that results in some tumor cells responding to chemotherapy.

The study, published this week in the online early edition of the Proceedings of the National Academy of Sciences, provides a novel approach to conquer tumor resistance to chemotherapy, and suggests an avenue for developing safe chemotherapy via naturally occurring agents.

Normally, cells have low levels of p53 diffused in their cytoplasm and nucleus. When DNA in the nucleus is damaged, p53 moves to the nucleus where it activates genes that stop cell growth and cause cell death. In this way, p53 ensures that cells with damaged DNA are killed.

In many cancers, p53 is rendered inactive by a process called cytoplasmic sequestration. Apigenin is able to activate p53 and transport it into the nucleus, resulting in a stop to cell growth and cell death.

"In therapy you want to kill cancer cells," explained Cai, the first author of the research paper. "But to stop cell growth and to kill the cell, p53 first needs to be moved to the cell's nucleus to function. Apigenin is very effective in localizing p53 this way."

Apigenin is mainly found in fruit (including apples, cherries, grapes), vegetables (including parsley, artichok
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert

Page: 1 2

Related biology news :

1. Gamma globulin effective in treating eye infections caused by adenoviruses
2. Eating competence may lower risk of heart disease
3. Alternative food networks connect ethical producers and consumers and can lead to healthier eating
4. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
5. Massive microRNA scan uncovers leads to treating muscle degeneration
6. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
7. Having the climate cake and eating it, too
8. Hellish hot springs yield greenhouse gas-eating bug
9. Tiny pest-eating insect fights fruit flies
10. Building disease-beating wheat
11. International scientists tackle obstacles to treating brain disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day m...ding to a new paper produced by a research team le...onto Scarborough,s vice-principal for research and...biology at the St. George campus. , Capitalizi...the poplar tree, the research team examined how po...
(Date:11/23/2009)... Farmington, CT Current research suggests that a...isease. The related report by Nichols et al, "Uni... a New Class of TLR2 Ligands Capable of Enhancing ...of The American Journal of Pathology . , Multip...em attacks the brain and spinal cord, affects near...
(Date:11/23/2009)... LIVERMORE, Calif. - By producing some of the hig...neral surfaces, scientists have a deeper understan...ls. This research may lead to a new treatment for ..., which appears in the Nov. 23 online edition of t... Sciences , explores how peptides interact with mi...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Navigaitor Helps Patients Walk Again 49126 1Navigaitor Helps Patients Walk Again 49126 2Navigaitor Helps Patients Walk Again 49126 3Navigaitor Helps Patients Walk Again 49126 4Navigaitor Helps Patients Walk Again 49126 5URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 1URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 2URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 3URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 4Assurant Employee Benefits Adds New Voluntary Capabilities 49122 1Assurant Employee Benefits Adds New Voluntary Capabilities 49122 2
... development could aid the treatment, and in some ...n babies in intensive care. , By providing vital i...he scanner avoids the need to move critically ill ...may involve sedating them and has a degree of risk... to diagnose and assess conditions such as brain h...
...regulatory gene that shows clear evidence of evolu...evolution of humans might well have depended in pa...phin (PDYN), that plays critical roles in regulati...d that, compared to lower primates, humans possess...the prodynorphin gene, which is a precursor molecu...
...nal of Experimental Medicine identifies a small ge... active tuberculosis (TB). Pedro Flores-Villanuev...alth Center (Tyler, TX) studied groups of patients...o carry this genetic change were more likely to de...ia. , Infections with Mycobacterium tuberculosis, ...
Other Biology News:New brain scan technology could save babies' lives 2Key brain regulatory gene shows evolution in humans 2Key brain regulatory gene shows evolution in humans 3Key brain regulatory gene shows evolution in humans 4Gene increases risk of tuberculosis 2
(Date:11/25/2009)...-- Biotech firm Replikins Ltd., which has analyzed...ic through the prediction, outbreak, and progress ...est biochemical analysis of the virus. The new dat...") virus has dropped from its peak of 3.7 (s.d. 4....ng of 2009 to resting non-epidemic levels this wee...
(Date:11/25/2009)... Cytochroma today announced the appointment of Pet... will replace Mr. Ulrik Spork as the Novo A/S repr...oard members remains unchanged at six members. ,...the board and look forward to benefiting from his ... make progress in becoming a leading CKD-focused s...
(Date:11/25/2009)...stCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ...resident and chief executive officer, will present...erence. , ,Presentation details are as follows:,...ate: Tuesday, December 1, 2009,Time: 2:0... Hotel, New York, NY,Webcast: <a href=,http://t...
(Date:11/24/2009)...sit Detroit , (Vocus) Nov...bassador for International Investment, and Chairma...What: Ambassador Appia is available to meet with p...opted by France to further develop the financial, ...evelopment., , ,When: Available for Interview on W...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...on, Inc. (Nasdaq: MDVN ) today announced that ...agement to discuss first quarter 2009 financial re...day, May 11, 2009, at 4:30 p.m. Eastern Time. A p... 2009 will be released after markets close on May ...-3376 from the U.S. or +1-719-325-4757 internation...
... Congressional Black Caucus Spring Health Braintru...misinformed about Alzheimer,s but support a screen... American and Hispanic adults are more concerned a...out prevention of and risk factors than Caucasians...by Eisai, Inc. Dr. Sharon Richardson, vice presid...
...Group at Frost & Sullivan is pleased to anno...ion on the Global Active Pharmaceutical Ingredient...09, at 3 p.m. GMT. , , (Logo: http://www.newscom...arket, traditionally dominated by small molecule d...s biopharmaceuticals. At the same time the manufac...
Other Biology Technology:Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009 2New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations 2New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations 3New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations 4The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics 2The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics 3
Goat Anti-HAS1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Frozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I from BioChain
Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue I from BioChain
MEGAscript RNAi Kit from Ambion
Biology Products: